Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Correlation between peripheral CA-125 levels and ovarian activity.

A Zweers1, J De Boever, R Serreyn

  • 1Department of Obstetrics and Gynecology, State University Hospital, Ghent, Belgium.

Fertility and Sterility
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review: Pork production with maximal nitrogen efficiency.

Animal : an international journal of animal bioscience·2017
Same author

The role of silver sulphadiazine in the conservative treatment of partial thickness burn wounds: A systematic review.

Burns : journal of the International Society for Burn Injuries·2016
Same author

Effect of particle size distribution and dietary crude fibre content on growth performance and gastric mucosa integrity of growing-finishing pigs.

Veterinary journal (London, England : 1997)·2011
Same author

Endoscopically assisted reduction of anterior table frontal sinus fractures.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery·2008
Same author

Primary lymphoma of the cervix uteri: a diagnostic challenge. Report of two cases and review of the literature.

European journal of gynaecological oncology·2005
Same author

Adenoid cystic carcinoma of the breast in a 19-year-old girl.

Breast (Edinburgh, Scotland)·2003

Serum CA-125 levels remain stable in normal or oral contraceptive cycles. However, women undergoing ovarian stimulation for fertility treatments like IVF or IUI experience a significant rise in CA-125 during the luteal phase.

Area of Science:

  • Reproductive Endocrinology
  • Gynecologic Oncology Biomarkers

Background:

  • CA-125 is a tumor marker often elevated in ovarian cancer.
  • Understanding CA-125 fluctuations in non-cancerous conditions is crucial for accurate interpretation.

Purpose of the Study:

  • To investigate the behavior of serum CA-125 levels during different phases of the menstrual cycle and in response to fertility treatments.
  • To differentiate CA-125 changes related to ovarian stimulation from those potentially indicative of pathology.

Main Methods:

  • Serum CA-125 was measured at three time points: early follicular, midcycle/oocyte retrieval, and mid-luteal phases.
  • Measurements were taken in normally cycling women, women on oral contraceptives, and patients undergoing stimulation for IVF and IUI.
  • Control groups included women undergoing laparoscopic sterilization.

Related Experiment Videos

Main Results:

  • No significant CA-125 variations were observed in normal or oral contraceptive cycles.
  • Significantly elevated CA-125 levels were found in the luteal phase of stimulated cycles for IVF (60.6 U/mL) and IUI (49.6 U/mL) compared to earlier phases.
  • CA-125 levels did not differ significantly before and after laparoscopic sterilization.

Conclusions:

  • Ovarian stimulation for fertility treatments causes a significant rise in serum CA-125 during the luteal phase.
  • This rise is distinct from CA-125 levels in normal cycles or after non-ovarian stimulating laparoscopic procedures.
  • Careful consideration of the patient's cycle status is necessary when interpreting elevated CA-125 levels.